Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
R. Patil, D. Taur, R. Patil (Kharadi, Pune, Malegaon BK, Baramati, District- Pune, India). Evaluation of bronchodilator activity of A. precatorius leaves. Eur Respir J 2013; 42: Suppl. 57, 679

Member's Comments

No comment yet.

Related content which might interest you: Bioactivity-guided isolation of bronchodilator fraction from clitoria ternatea roots Source: Annual Congress 2013 –Novel drugs and biomarkers in respiratory medicine Year: 2013 In-vitro bronchodilator activity clitoria ternatea and A. precatorius Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases Year: 2013 Occupational asthma to ’the miracle tree’ (Moringa oleifera): First description Source: International Congress 2015 – Occupational disease: clinical cases and series Year: 2015 Standardization of a murine model of asthma due to soybean inhalation Source: International Congress 2015 – Occupational and environmental effects: in vitro and animal models Year: 2015 Zizyphus spina-christi for the management of adult asthma Source: Annual Congress 2013 –Novel drugs and biomarkers in respiratory medicine Year: 2013 Effects of rosemary and platanus extracts on asthmatic subjects resistant to traditional treatments Source: Annual Congress 2013 –Novel drugs and biomarkers in respiratory medicine Year: 2013 Investigating antioxidant therapy for steroid-resistant asthma Source: International Congress 2016 – Asthma: mechanisms and biomarkers that promote clinical understanding Year: 2016 Characterisation of a steroid-insensitive severe asthma model Source: International Congress 2014 – Animal models in respiratory drug development Year: 2014 Sakuranetin treatment from baccharis retusa reduces acid mucus in a murine model of asthma Source: International Congress 2016 – Preclinical pharmacology: drug targets and mechanisms of action Year: 2016 Polyphenolic compounds and experimentally induced allergic asthma Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation Year: 2013 The effect of different PV extracts in the treatment of asthma in an animal model Source: International Congress 2015 – Immune aspects of asthma and other airway diseases Year: 2015 Effectiveness of 15-deoxy-delta-12-14-prostaglandin J2 on established asthma pathological changes triggered by house dust mite in mice Source: International Congress 2015 – Novel targets and strategies for the treatment of cough, asthma, rhinosinusitis and COPD Year: 2015 Oral administration of saccharomyces cerevisiae inhibits the allergic airway response in mice Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases Year: 2013 In vitro characterization of a novel inhaled PI3Kd inhibitor LAS194223 Source: International Congress 2014 – New treatments for cough, asthma, COPD and ILDs Year: 2014 In vitro profile of the new inhaled pan-JAK inhibitor LAS194046 Source: International Congress 2014 – New treatments for cough, asthma, COPD and ILDs Year: 2014 The effects of clinically relevant reference agents in a mouse model of severe asthma Source: International Congress 2015 – Advances in the future treatment of severe asthma Year: 2015 Potential effect of the extract of zataria multiflora and its consituent carvacrol on lung inflammation of sensitized guinea pigs Source: Annual Congress 2013 –Novel drugs and biomarkers in respiratory medicine Year: 2013 Study of antioxidant use in patients with asthma exacerbations Source: Annual Congress 2013 –Asthma drugs: new findings Year: 2013 Immunomodulatory role of IL-37 in asthma pathogenesis Source: International Congress 2016 – Immune responses in the lung Year: 2016 Protein identification of two allergens of boletus edulis causing occupational asthma Source: Annual Congress 2013 –Environmental and occupational respiratory diseases: new exposure assessment methods, experimental exposure in animal and humans and mechanisms Year: 2013